-
Mashup Score: 0
The Senate confirmation hearing for NCI Director Monica Bertagnolli, who has been nominated for the job of NIH director, has been scheduled for Oct. 18. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Study investigates cancer among people experiencing homelessness to form basis for prevention program - The Cancer Letter - 2 year(s) ago
A team headed by the Medical University of Vienna examined cancer prevalence and screening/prevention awareness among people who are experiencing homelessness in four European countries. The team proposed approaches for the development of a prevention program using the results. The study was published in eClinicalMedicine. To access this subscriber-only content please log in or renew […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Study investigates cancer among people experiencing homelessness to form basis for prevention program. https://t.co/rhEM6uuS2k https://t.co/zhbmtZ0fLK
-
-
Mashup Score: 0Evaluation of COE requires a holistic approach; avoiding two fundamental fallacies - The Cancer Letter - 2 year(s) ago
Progress against cancer, as brought about by high quality academic cancer centers, requires individual excellence from experts who apply distinct, highly specific skill sets to a common goal within the cancer center. The cancer center coordinates and supports these efforts. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@UIowaCancer's George Weiner: "Every element of a cancer center...should be able to articulate the needs and priorities in their catchment area and how program priorities, directly or indirectly, address such needs." https://t.co/iIO8FiyOcb
-
-
Mashup Score: 1SCOTUS decision on denying service to LGBTQ+ people opens doors for discrimination in cancer care - The Cancer Letter - 2 year(s) ago
At first glance, the United States Supreme Court’s 303 Creative LLC. v. Elenis ruling has nothing to do with health care—but, looking deeper, experts in oncology and law are sounding alarms that the decision can be used to discriminate against LGBTQ+ patients. To access this subscriber-only content please log in or renew your subscription.Looking for […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@CliffordHudis (@ASCO): "Any action...that erodes anti-discrimination protections, has the potential to exacerbate those existing disparities and worsen a community’s access to services. That’s across all of society, and it includes healthcare." https://t.co/SWjso5tuqW
-
-
Mashup Score: 0
The fiscal year 2024 Labor, HHS, Education, and Related Agencies spending bill heading for approval by the House Appropriations Committee cuts NIH by $2.8 billion and NCI by $216 million. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
"Regardless of age or stage in life, this bill means you cannot count on government for any help. It limits women’s access to abortion while stripping maternal health services and making diapers more expensive.” - @rosadelauro https://t.co/GaPDCanboS
-
-
Mashup Score: 0Sylvester researchers target treatment-resistant prostate cancer with oral chemo in preclinical study - The Cancer Letter - 2 year(s) ago
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an orally administered drug to disrupt prostate cancer cells’ metabolism and deliver the chemotherapy agent cisplatin directly into treatment-resistant prostate cancer cells. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login?…
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@SylvesterCancer researchers target treatment-resistant prostate cancer with oral chemo in preclinical study. https://t.co/qzKV7178Zx https://t.co/31WkPuCsr0
-
-
Mashup Score: 0Using ctDNA as an endpoint in your cancer clinical trial? FDA wants to hear from you - The Cancer Letter - 2 year(s) ago
Circulating tumor DNA has the potential to not only change the way medical oncologists assess and treat cancer patients, but also how cancer drugs are reviewed, oncology experts at FDA and pharmaceutical companies said in response to research findings published July 11 by a collaboration led by Friends of Cancer Research. To access this subscriber-only […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Circulating tumor DNA has the potential to not only change the way medical oncologists assess and treat cancer patients, but also how cancer drugs are reviewed, experts said in response to @CancerResrch-led research findings. https://t.co/AkREzN4Z7r
-
-
Mashup Score: 3
The U.S. Preventive Services Task Force’s new guidelines to offer mammography from age 40 will save many lives. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@KemiMDRad & Vivian Jolley Bea: "We need to personalize screening. A one-size-fits-all doesn’t work for high-risk groups like Black women. We realize personalized medicine isn’t convenient in our fast-paced, profit-focused world, but we must try." https://t.co/c4cCOv66Tz
-
-
Mashup Score: 0Evaluation of COE requires a holistic approach; avoiding two fundamental fallacies - The Cancer Letter - 2 year(s) ago
Progress against cancer, as brought about by high quality academic cancer centers, requires individual excellence from experts who apply distinct, highly specific skill sets to a common goal within the cancer center. The cancer center coordinates and supports these efforts. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
.@UIowaCancer's George Weiner: "When you have seen one COE, you have seen one COE." https://t.co/iIO8FiyOcb
-
-
Mashup Score: 1Some cases of Lynch syndrome are missed in younger patients under current screening guidelines - The Cancer Letter - 2 year(s) ago
Cedars-Sinai Cancer investigators found that some cases of Lynch syndrome, the most common hereditary cancer condition, are missed in younger patients under current screening guidelines. To access this subscriber-only content please log in or renew your subscription.Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please […]
Source: The Cancer LetterCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Some cases of Lynch syndrome are missed in younger patients under current screening guidelines. https://t.co/N2rLTsa0LY https://t.co/xyhnrGlerQ
-
Monica Bertagnolli’s (@NCIDirector) @NIH confirmation hearing scheduled. https://t.co/roaHAqoD7o https://t.co/SUcyo0JjY5